REGENERATIVE MEDICINE
We provide innovative solutions to address unmet needs in current medical technology.
We are committed to the development of high quality, safe, and cost-effective solutions that significantly improve patient outcomes.
helping people heal
Modern medicine is making progress in how we can treat severe injuries, but even with today's technology, there are limits to how we can help heal wounded patients.
Stemsys®, was founded and the multi-tissue platform (MTP) developed in an effort to overcome limitations of tissue devices developed to date and help heal even the most severely injured.
Wound healing and tissue regeneration is complex.
-
Stemsys MTP Technology
Injured or damaged tissue requires multiple biomolecules to facilitate injury site healing. Many of these biomolecules have been identified in extracellular matrix (ECM).
-
XCelliStem Wound Powder
Product derived from the multi-tissue platform (MTP). A custom blend of multiple tissues offers the body more biomolecules that are needed to facilitate healing.
-
clinical case series
Application of the MTP powder can be performed in the presence of an infection while achieving superior healing outcomes, saving treatment time for both the patient and the clinician.
the future of healing starts here.
To date, ECM wound products have been derived from one tissue source, limiting the quantity and variety of biomolecules in the medical device. The multi-tissue platform (MTP) has now been developed.
revolutionizing the way people heal.
No longer limited to the biomolecules of a single ECM, the Stemsys MTP combines multiple tissue sources in varying ratios providing the body access to more biomolecules.
With over 20 years of experience working in the field of tissue regeneration, Stemsys is committed to developing novel medical devices that help restore the function of disease or injured tissue and help even the most severely injured heal.
“‘Magic powder' heals wounds nothing else can” - ABC News, 2018